{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:55:24Z","timestamp":1775598924826,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200173"],"award-info":[{"award-number":["81200173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370338"],"award-info":[{"award-number":["81370338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470511"],"award-info":[{"award-number":["81470511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570354"],"award-info":[{"award-number":["81570354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"crossref","award":["S2013020012578"],"award-info":[{"award-number":["S2013020012578"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"crossref","award":["2015A030313111"],"award-info":[{"award-number":["2015A030313111"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ph.D. Programs Foundation of Ministry of Education of China","award":["20120171110074"],"award-info":[{"award-number":["20120171110074"]}]},{"name":"Guangdong Scientific Program Foundation","award":["2012B031800300"],"award-info":[{"award-number":["2012B031800300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s11010-017-3020-2","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T16:20:41Z","timestamp":1494519641000},"page":"113-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1\/2"],"prefix":"10.1007","volume":"433","author":[{"given":"Bin","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruicong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"key":"3020_CR1","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1038\/ncomms7656","volume":"6","author":"VB Pillai","year":"2015","unstructured":"Pillai VB, Samant S, Sundaresan NR, Raghuraman H, Kim G, Bonner MY, Arbiser JL, Walker DI, Jones DP, Gius D, Gupta MP (2015) Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt 3. Nat Commun 6:6656. doi:\n10.1038\/ncomms7656","journal-title":"Nat Commun"},{"key":"3020_CR2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmet.2013.08.018","volume":"18","author":"JH Lee","year":"2013","unstructured":"Lee JH, Budanov AV, Karin M (2013) Sestrins orchestrate cellular metabolism to attenuate aging. Cell Metab 18:792\u2013801. doi:\n10.1016\/j.cmet.2013.08.018","journal-title":"Cell Metab"},{"issue":"Part B","key":"3020_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.freeradbiomed.2015.06.007","volume":"88","author":"SG Rhee","year":"2015","unstructured":"Rhee SG, Bae SH (2015) The antioxidant function of Sestrins is mediated by promotion of autophagic degradation of Keap1 and Nrf2 activation and by inhibition of mTORC1. Free Radic Biol Med 88(Part B):205\u2013211. doi:\n10.1016\/j.freeradbiomed.2015.06.007","journal-title":"Free Radic Biol Med"},{"key":"3020_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cell.2014.08.038","volume":"159","author":"M Peng","year":"2014","unstructured":"Peng M, Yin N, Li MO (2014) Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling. Cell 159:122\u2013133. doi:\n10.1016\/j.cell.2014.08.038","journal-title":"Cell"},{"key":"3020_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cell.2008.06.028","volume":"134","author":"AV Budanov","year":"2008","unstructured":"Budanov AV, Karin M (2008) P53 target genes Sestrin 1 and Sestrin 2 connect genotoxic stress and mTOR signaling. Cell 134:451\u2013460. doi:\n10.1016\/j.cell.2008.06.028","journal-title":"Cell"},{"key":"3020_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1126\/science.aad2087","volume":"351","author":"RA Saxton","year":"2016","unstructured":"Saxton RA, Knockenhauer KE, Wolfson RL, Chantranupong L, Pacold ME, Wang T, Schwartz TU, Sabatini DM (2016) Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science 351:53\u201358. doi:\n10.1126\/science.aad2087","journal-title":"Science"},{"key":"3020_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/HYPERTENSIONAHA.114.03840","volume":"64","author":"Y Yang","year":"2014","unstructured":"Yang Y, Cuevas S, Yang S, Villar VA, Escano C, Asico L, Yu P, Jiang X, Weinman EJ, Armando I, Jose PA (2014) Sestrin 2 decreases renal oxidative stress, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of reactive oxygen species production. Hypertension 64:825\u2013832. doi:\n10.1161\/HYPERTENSIONAHA.114.03840","journal-title":"Hypertension"},{"key":"3020_CR8","doi-asserted-by":"publisher","first-page":"10025","DOI":"10.1038\/ncomms10025","volume":"6","author":"H Kim","year":"2015","unstructured":"Kim H, An S, Ro SH, Teixeira F, Park GJ, Kim C, Cho CS, Kim JS Jakob U, Lee JH, Cho US (2015) Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains. Nat Commun 6:10025. doi:\n10.1038\/ncomms10025","journal-title":"Nat Commun"},{"key":"3020_CR9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/science.1095569","volume":"304","author":"AV Budanov","year":"2004","unstructured":"Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM (2004) Regeneration of peroxiredoxins by p53-regulated Sestrins, homologs of bacterial AphD. Science 304:596\u2013600. doi:\n10.1126\/science.1095569","journal-title":"Science"},{"key":"3020_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cmet.2012.12.002","volume":"17","author":"SH Bae","year":"2013","unstructured":"Bae SH, Sung SH, Oh SY, Lim JM, Lee SK, Park YN, Lee HE, Kang D, Rhee SG (2013) Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab 17:73\u201384. doi:\n10.1016\/j.cmet.2012.12.002","journal-title":"Cell Metab"},{"key":"3020_CR11","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1089\/ars.2012.4958","volume":"19","author":"W Kallenborn-Gerhardt","year":"2013","unstructured":"Kallenborn-Gerhardt W, Lu R, Syhr KM, Heidler J, von Melchner H, Geisslinger G, Bangsow T, Schmidtko A (2013) Antioxidant activity of Sestrin 2 controls neuropathic pain after peripheral nerve injury. Antioxid Redox Signal 19:2013\u20132023. doi:\n10.1089\/ars.2012.4958","journal-title":"Antioxid Redox Signal"},{"key":"3020_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.celrep.2014.10.019","volume":"9","author":"A Parmigiani","year":"2014","unstructured":"Parmigiani A, Nourbakhsh A, Ding B, Wang W, Kim YC, Akopiants K, Guan KL, Karin M, Budanov AV (2014) Sestrins inhibit mTORC1 kinase activation through the GATOR complex. Cell Rep 9:1281\u20131291. doi:\n10.1016\/j.celrep.2014.10.019","journal-title":"Cell Rep"},{"key":"3020_CR13","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1128\/MCB.00285-15","volume":"35","author":"YS Hou","year":"2015","unstructured":"Hou YS, Guan JJ, Xu HD, Wu F, Sheng R, Qin ZH (2015) Sestrin2 protects dopaminergic cells against rotenone toxicity through AMPK-dependent autophagy activation. Mol Cell Biol 35:2740\u20132751. doi:\n10.1128\/MCB.00285-15","journal-title":"Mol Cell Biol"},{"key":"3020_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1096\/fj.14-258814","volume":"29","author":"A Morrison","year":"2015","unstructured":"Morrison A, Chen L, Wang J, Zhang M, Yang H, Ma Y, Budanov A, Lee JH, Karin M, Li J (2015) Sestrin 2 promotes LKB1-mediated AMPK activation in the ischemic heart. FASEB J 29:408\u2013417. doi:\n10.1096\/fj.14-258814","journal-title":"FASEB J"},{"key":"3020_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00411-016-0643-8","volume":"55","author":"YC Zeng","year":"2016","unstructured":"Zeng YC, Chi F, Xing R, Zeng J, Gao S, Chen JJ, Wang HM, Duan QY, Sun YN, Niu N, Tang MY, Wu R (2016) Sestrin2 protects the myocardium against radiation-induced damage. Radiat Environ Biophys 55:195\u2013202. doi:\n10.1007\/s00411-016-0643-8","journal-title":"Radiat Environ Biophys"},{"key":"3020_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M (2001) Mammalian MAP kinase signaling cascades. Nature 410:37\u201340. doi:\n10.1038\/35065000","journal-title":"Nature"},{"key":"3020_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pharmthera","volume":"144","author":"S Javadov","year":"2014","unstructured":"Javadov S, Jang S, Agostini B (2014) Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives. Pharmacol Ther 144:202\u2013225. doi:\n10.1016\/j.pharmthera","journal-title":"Pharmacol Ther"},{"key":"3020_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00395-012-0326-9","volume":"108","author":"J Lu","year":"2013","unstructured":"Lu J, Bian ZY, Zhang R, Zhang Y, Liu C, Yan L, Zhang SM, Jiang DS, Wei X, Zhu XH, Chen M, Wang AB, Chen Y, Yang Q, Liu PP, Li H (2013) Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic Res Cardiol 108:326. doi:\n10.1007\/s00395-012-0326-9","journal-title":"Basic Res Cardiol"},{"key":"3020_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1042\/CS20070430","volume":"115","author":"AJ Muslin","year":"2008","unstructured":"Muslin AJ (2008) MAPK signaling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci 115:203\u2013218. doi:\n10.1042\/CS20070430","journal-title":"Clin Sci"},{"key":"3020_CR20","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.biocel.2008.02.020","volume":"40","author":"SP Barry","year":"2008","unstructured":"Barry SP, Davidson SM, Townsend PA (2008) Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 40:2023\u20132039. doi:\n10.1016\/j.biocel.2008.02.020","journal-title":"Int J Biochem Cell Biol"},{"key":"3020_CR21","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/01.RES.78.6.954","volume":"78","author":"PE Glennon","year":"1996","unstructured":"Glennon PE, Kaddoura S, Sale EM, Sale JG, Fuller SJ, Sugden PH (1996) Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res 78:954\u2013961. doi:\n10.1161\/01.RES.78.6.954","journal-title":"Circ Res"},{"key":"3020_CR22","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","volume":"19","author":"OF Bueno","year":"2000","unstructured":"Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD (2000) The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19:6341\u20136350. doi:\n10.1093\/emboj\/19.23.6341","journal-title":"EMBO J"},{"key":"3020_CR23","doi-asserted-by":"publisher","first-page":"37895","DOI":"10.1074\/jbc.M007037200","volume":"275","author":"TL Yue","year":"2000","unstructured":"Yue TL, Gu JL, Wang C, Reith AD, Lee JC, Mirabile RC, Kreutz R, Wang Y, Maleeff B, Parsons AA, Ohlstein EH (2000) Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem 275:37895\u201337901. doi:\n10.1074\/jbc.M007037200","journal-title":"J Biol Chem"},{"key":"3020_CR24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.yjmcc.2003.10.001","volume":"35","author":"Q Liang","year":"2003","unstructured":"Liang Q, Molkentin JD (2003) Redefining roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol 35:1385\u20131394. doi:\n10.1016\/j.yjmcc.2003.10.001","journal-title":"J Mol Cell Cardiol"},{"key":"3020_CR25","doi-asserted-by":"publisher","first-page":"12661","DOI":"10.1073\/pnas.1301455110","volume":"110","author":"M Volkers","year":"2013","unstructured":"Volkers M, Toko H, Doroudgar S, Din S, Quijada P, Joyo AY, Ornrlas L, Joyo E, Thyerauf DJ, Konstandin MH, Gude N, Glembotski CC, Sussman MA (2013) Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1. Proc Natl Acad Sci USA 110:12661\u201312666. doi:\n10.1073\/pnas.1301455110","journal-title":"Proc Natl Acad Sci USA"},{"key":"3020_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/emmm.201201369","volume":"5","author":"RH Wang","year":"2013","unstructured":"Wang RH, He JP, Su ML, Luo J, Xu M, Du XD, Chen HZ, Wang WJ, Wang Y, Zhang N, Zhao BX, Zhao WX, Shan ZG, Han J, Chang C, Wu Q (2013) The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signaling. EMBO Mol Med 5:137\u2013148. doi:\n10.1002\/emmm.201201369","journal-title":"EMBO Mol Med"},{"key":"3020_CR27","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/hmg\/ddq570","volume":"20","author":"AJ Malhowski","year":"2011","unstructured":"Malhowski AJ, Hira H, Bashiruddin S, Warburton R, Goto J, Robert B, Kwiatkowski DJ, Finalay GA (2011) Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin. Hum Mol Genet 20:1290\u20131305. doi:\n10.1093\/hmg\/ddq570","journal-title":"Hum Mol Genet"},{"key":"3020_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/0008-5472.CAN-14-1854","volume":"75","author":"P Pettazzoni","year":"2011","unstructured":"Pettazzoni P, Viale A, Shah P, Carugo A, Ying H, Wang H, Genovese G, Seth S, Minelli R, Green T, Huang-Hobbs E, Corti D, Sanchez N, Nezi L, Marchesini M, Kapoor A, Yao W, Francesco ME, Petrocchi A, Deem AK, Scott K, Colla S, Mills GB, Fleming JB, Heffernan TP, Jones P, Toniatti C, DePinho RA, Draetta GF (2011) Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer. Cancer Res 75:1091\u20131101. doi:\n10.1158\/0008-5472.CAN-14-1854","journal-title":"Cancer Res"},{"key":"3020_CR29","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-11-3747","volume":"72","author":"AB Turke","year":"2012","unstructured":"Turke AB, Song Y, Costa C, Cook R, Arteaga CL, Asara JM, Engelman JA (2012) MEK inhibition leads to PI3K\/AKT activation by relieving a negative feedback on ERBB receptors. Cancer Res 72:3228\u20133237. doi:\n10.1158\/0008-5472.CAN-11-3747","journal-title":"Cancer Res"},{"key":"3020_CR30","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1172\/JCI34739","volume":"118","author":"A Carracedo","year":"2008","unstructured":"Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP (2008) Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Investig 118:3065\u20133074. doi:\n10.1172\/JCI34739","journal-title":"J Clin Investig"},{"key":"3020_CR31","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.pain.2013.03.021","volume":"154","author":"OK Melemedjian","year":"2013","unstructured":"Melemedjian OK, Khoutorsky A, Sorge RE, Yan J, Asiedu MN, Valdez A, Ghosh S, Dussor G, Mogil JS, Sonenberg N, Price TJ (2013) mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK. Pain 154:1080\u20131091. doi:\n10.1016\/j.pain.2013.03.021","journal-title":"Pain"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-017-3020-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-017-3020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-017-3020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T02:25:36Z","timestamp":1502504736000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-017-3020-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3020"],"URL":"https:\/\/doi.org\/10.1007\/s11010-017-3020-2","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}